BIODESIX INC — Director's Dealing 2022

Apr 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2022-03-31

Reporting Person: Franchi Jean M. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-31	Common Stock	M	20044	—	Acquired	20044	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-31	Restricted Stock Units	$	M	20044	Disposed		Common Stock (20044)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F2: These restricted stock units vested in full on March 31, 2022 and had no expiration date.